Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?

NCT01997762 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT01997762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01997762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?
Lead sponsor
University of Manitoba
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2014
Completion date
December 31, 2016
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes